MMA Embolization: A Novel Procedure for Recurrent Brain Bleeds

MMA Embolization: A Novel Procedure for Recurrent Brain Bleeds

A chronic subdural hematoma (cSDH) is an accumulation of old blood and fluid breakdown products located between the surface of the brain and its outer dural membrane. Most common in older adults, individuals on long-term blood thinners, or patients with brain volume loss, chronic subdural hematomas often develop after minor, unnoticed head trauma.

While large hematomas causing brain compression traditionally require surgical drainage through burr holes, chronic subdural hematomas have recurrence rates as high as 20%. Middle Meningeal Artery (MMA) Embolization offers a modern endovascular procedure designed to eliminate the root cause of recurrent bleeding.

The Cycle of Chronic Subdural Bleeding

When a blood collection forms in the subdural space, the body responds by surrounding it with a thin, fibrous membrane. However, this outer membrane forms abnormal, fragile micro-blood vessels (neocapillaries).

These fragile micro-vessels leak repeatedly, creating a continuous cycle of micro-hemorrhage and fluid expansion that prevents the hematoma from resolving naturally.

The primary blood supply feeding these leaky membrane vessels comes from the Middle Meningeal Artery (MMA)—a branch of the external carotid artery located along the inner skull wall.

How MMA Embolization Interrupts the Cycle

MMA Embolization is a minimally invasive endovascular procedure performed in an angiography suite:

1. Microcatheter Navigation: An endovascular specialist accesses the arterial system through a tiny puncture in the wrist (radial artery) or groin (femoral artery) and navigates a microcatheter up to the middle meningeal artery inside the skull.
2. Targeted Occlusion: Guided by digital subtraction angiography (DSA), tiny liquid embolic agents (such as Onyx) or micro-particles are injected into the specific MMA branches feeding the hematoma membrane.
3. Hematoma Resolution: Blocking blood flow starves the fragile neocapillaries. Without ongoing micro-bleeds, the body reabsorbs the existing subdural fluid collection over several weeks.

Clinical Advantages and Patient Outcomes

Middle Meningeal Artery Embolization provides clear clinical benefits:

• Standalone Treatment: Can serve as a non-surgical intervention for stable, symptomatic chronic subdural hematomas.
• Prevents Surgical Recurrence: When combined with burr hole drainage for large hematomas, it significantly reduces the likelihood of recurrent bleeding.
• Minimally Invasive: Performed under light sedation, allowing patients to recover with lower overall procedure risks.

• Book Online: Visit igeaneuro.com to request a comprehensive diagnostic consultation with our neurovascular team.
• Call Our Team Today: Speak directly with our dedicated patient care coordinators at (866) 467-1770.